Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial Experience
- 1 January 2008
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 190 (1), 91-98
- https://doi.org/10.2214/ajr.07.2384
Abstract
OBJECTIVE. Our objective was to assess the feasibility, safety, and efficacy of percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma (HCC) in the hepatic dome. MATERIALS AND METHODS. Sonographically guided percutaneous radiofrequency ablation with artificial ascites was performed in 25 patients with 34 HCCs using an internally cooled electrode radiofrequency system. At least one hepatic dome tumor in each patient was considered difficult to treat percutaneously because of partially visible tumor (n = 16) or poor electrode path (n = 9) on planning sonography. We artificially induced ascites before radiofrequency ablation by dripping 5% dextrose in water (D/W) solution to improve tumor visibility or electrode path and to separate the radiofrequency ablation zone from the diaphragm. We assessed the technical feasibility, safety, and efficacy of this technique with clinical and CT follow-up for at least 4 months (mean, 281.4 days) RESULTS. Artificial ascites was successfully achieved in 22 (88%) of 25 patients with the administration of a mean of 348 mL of D/W solution for an additional mean time of 9.3 minutes. There was substantial improvement in the visibility in 93.4% (15/16) of the partially visible tumors and in achieving a better path in 77.8% (7/9) of the tumors with a poor electrode path. The primary technique effectiveness rate for hepatic dome tumors was 96% (24/25) at 1-month follow-up CT. There was no diaphragmatic thermal injury in all but one case. No complication related to artificial ascites occurred during the follow-up period. CONCLUSION. Percutaneous radiofrequency ablation with artificial ascites appears a feasible, safe, and effective technique for treating HCC of the hepatic dome.Keywords
This publication has 33 references indexed in Scilit:
- A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular CarcinomaGastroenterology, 2005
- Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective reviewEuropean Journal of Surgical Oncology, 2005
- Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency AblationRadiology, 2005
- Percutaneous radiofrequency ablation for hepatocellular carcinomaCancer, 2005
- Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cmGastroenterology, 2004
- Hepatocellular carcinoma: Current surgical managementGastroenterology, 2004
- Percutaneous Sonographically Guided Radiofrequency Ablation with Artificial Pleural Effusion for Hepatocellular Carcinoma Located Under the DiaphragmAmerican Journal of Roentgenology, 2004
- Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-frequency Thermal Ablation versus Percutaneous Ethanol InjectionRadiology, 2003
- Radiofrequency Ablation of the LiverAmerican Journal of Roentgenology, 2001
- Minimally Invasive Treatment of Malignant Hepatic Tumors: At the Threshold of a Major BreakthroughRadioGraphics, 2000